Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MSGS
MSGS logo

MSGS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Madison Square Garden Sports Corp (MSGS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
321.400
1 Day change
2.77%
52 Week Range
345.460
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Madison Square Garden Sports Corp (MSGS) is not a strong buy for a beginner, long-term investor at this moment. While there are some positive catalysts such as potential spin-offs and analyst upgrades, the lack of significant trading signals, weak financial performance, and neutral technical indicators suggest that waiting for a clearer entry point may be prudent.

Technical Analysis

The MACD is below 0 and negatively contracting, RSI is neutral at 52.857, and moving averages are converging, indicating no strong trend. The stock is trading near its pivot level of 313.53, with resistance at 320.784 and support at 306.275.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
2
Buy
13

Positive Catalysts

  • Analyst upgrades with increased price targets and potential spin-off of the New York Knicks and Rangers, which could unlock value.

Neutral/Negative Catalysts

  • Weak financial performance with a 25.99% YoY revenue drop and declining gross margin. No significant hedge fund or insider trading activity. Stock trend analysis suggests a potential short-term decline.

Financial Performance

In Q1 2026, revenue dropped 25.99% YoY to $39.45M. Net income improved but remains negative at -$8.81M. EPS increased to -0.37, up 19.35% YoY. Gross margin dropped to 80.28%, down 6.20% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are generally positive, with recent upgrades from JPMorgan, Citi, and Susquehanna. Price targets range from $295 to $400, reflecting optimism about potential spin-offs and valuation improvements.

Wall Street analysts forecast MSGS stock price to fall
5 Analyst Rating
Wall Street analysts forecast MSGS stock price to fall
2 Buy
3 Hold
0 Sell
Moderate Buy
Current: 312.730
sliders
Low
220
Averages
250
High
290
Current: 312.730
sliders
Low
220
Averages
250
High
290
JPMorgan
Overweight
maintain
$305 -> $400
AI Analysis
2026-02-19
Reason
JPMorgan
Price Target
$305 -> $400
AI Analysis
2026-02-19
maintain
Overweight
Reason
JPMorgan raised the firm's price target on MSG Sports to $400 from $305 and keeps an Overweight rating on the shares after the company announced that its board approved plans to explore a possible separation of the New York Knicks and New York Rangers into separately traded public companies through a tax-free spin-off. JPMorgan views "explore" as a high intention to execute.
Citi
Jason Bazinet
Buy
maintain
$290 -> $337
2026-02-13
Reason
Citi
Jason Bazinet
Price Target
$290 -> $337
2026-02-13
maintain
Buy
Reason
Citi analyst Jason Bazinet raised the firm's price target on MSG Sports to $337 from $290 and keeps a Buy rating on the shares. The company has said it remains open to a potential minority stake sale, which could help close the stock's valuation gap relative to the private market, the analyst tells investors in a research note. Citi rolled forward the stock's valuation to fiscal 2027.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MSGS
Unlock Now

People Also Watch